Table: AFC-HD AMS Life Science -2025/26 group results
15/10/2026 07:35
Oct 15 (Reuters)-
AFC-HD AMS Life Science
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Aug 31, 2026 Aug 31, 2025 Aug 31, 2027 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 34.32 32.66 35.47 17.61
(+5.1 pct) (+8.2 pct) (+3.3 pct) (+4.5 pct)
Operating 2.46 2.41 2.62 1.27
(+1.9 pct) (+25.7 pct) (+6.9 pct) (+1.7 pct)
Recurring 2.39 2.44 2.51 1.22
(-2.2 pct) (+27.2 pct) (+5.1 pct) (+1.7 pct)
Net 1.20 1.45 1.66 815 mln
(-17.2 pct) (+15.7 pct) (+38.3 pct) (+1.8 pct)
EPS 82.89 yen 102.98 yen 113.88 yen 56.03 yen
EPS Diluted -- 102.97 yen --
Ann Div 40.00 yen 34.00 yen 44.00 yen
-Q2 div 18.00 yen 16.00 yen 22.00 yen
-Q4 div 22.00 yen 18.00 yen 22.00 yen
NOTE - AFC-HD AMS Life Science.
*Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T